The same authors also found that T3 treatment significantly downregulates AQP4 in human glioblastoma cells, thus suggesting that higher TH concentration might have a better outcome in reducing AQP4 in brain cancer cells and, hence, in reducing tumor cell migration ability [283]. This evidence concerns the gene AQP4 and glioblastoma.